Skip to main content

Natural history of renal cell carcinoma.

Publication ,  Journal Article
Paulson, DF
Published in: Semin Urol Oncol
November 1996

The survival of patients with renal cell carcinoma is directly related to the extent of malignancy at the time of treatment. Patients with T1 and T2 disease experience excellent survival independent of the grade of the disease. However, once the disease has extended from the kidney, survival is a function of whether the disease progresses by direct extension or has the ability to move through space and deposit at distant metastatic sites. When this occurs, survival is almost directly a function of the grade and degree of malignancy of the renal tumor.

Duke Scholars

Published In

Semin Urol Oncol

ISSN

1081-0943

Publication Date

November 1996

Volume

14

Issue

4

Start / End Page

203 / 207

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Survival Rate
  • Risk Factors
  • Prognosis
  • Neoplasm Metastasis
  • Kidney Neoplasms
  • Humans
  • Clinical Trials as Topic
  • Carcinoma, Renal Cell
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Paulson, D. F. (1996). Natural history of renal cell carcinoma. Semin Urol Oncol, 14(4), 203–207.
Paulson, D. F. “Natural history of renal cell carcinoma.Semin Urol Oncol 14, no. 4 (November 1996): 203–7.
Paulson DF. Natural history of renal cell carcinoma. Semin Urol Oncol. 1996 Nov;14(4):203–7.
Paulson, D. F. “Natural history of renal cell carcinoma.Semin Urol Oncol, vol. 14, no. 4, Nov. 1996, pp. 203–07.
Paulson DF. Natural history of renal cell carcinoma. Semin Urol Oncol. 1996 Nov;14(4):203–207.

Published In

Semin Urol Oncol

ISSN

1081-0943

Publication Date

November 1996

Volume

14

Issue

4

Start / End Page

203 / 207

Location

United States

Related Subject Headings

  • Urology & Nephrology
  • Survival Rate
  • Risk Factors
  • Prognosis
  • Neoplasm Metastasis
  • Kidney Neoplasms
  • Humans
  • Clinical Trials as Topic
  • Carcinoma, Renal Cell
  • 3211 Oncology and carcinogenesis